The global tissue plasminogen activator market is estimated to be valued at US$ 614.9 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period of 2024 to 2030.
Tissue plasminogen activator (tPA) is a protein involved in the breakdown of blood clots. It helps restore blood flow by dissolving clots and is primarily used for the treatment of ischemic stroke and myocardial...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian